Sara Bravaccini

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 34

Top Venues

International journal of molecular sciences

Cell transplantation

Breast cancer research and treatment

Biomedicines

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS

University of Bologna Biocomputing Group (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS

Italy

Research biologist :: Biosciences Laboratory

Education History

University of Bologna Biocomputing Group - May 12 2014

Italy

PHD

Publications

Roberta Maltoni, Andrea Roncadori, William Balzi, Massimiliano Mazza, Fabio Nicolini, Michela Palleschi, Paola Ulivi, Sara Bravaccini
An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy. Biomedicines 12 (3) (2024)
Iros Barozzi, Neil Slaven, Eleonora Canale, Rui Lopes, Inês A M Barbosa, Melusine Bleu, Diana Ivanoiu, Claudia Pacini, Emanuela Mensa, Alfie Chambers, Sara Bravaccini, Sara Ravaioli, Gyorffy Balazs, Maria Vittoria Dieci, Giancarlo Pruneri, Giorgio Giacomo Galli, Luca Magnani
A functional survey of the regulatory landscape of estrogen-receptor-positive breast cancer evolution. Cancer discovery (2024)
Roberta Maltoni, Andrea Roncadori, William Balzi, Massimiliano Mazza, Fabio Nicolini, Michela Palleschi, Paola Ulivi, Sara Bravaccini
An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy. Biomedicines 12 (3) (2024)
Sara Bravaccini, Massimiliano Mazza, Roberta Maltoni
No more disparities among regions in Italy: recent approval of genomic test reimbursability for early breast cancer patients in the country. Breast cancer research and treatment (2023)
Maria Maddalena Tumedei, Filippo Piccinini, Irene Azzali, Francesca Pirini, Sara Bravaccini, Serena De Matteis, Claudio Agostinelli, Gastone C Castellani, Michele Zanoni, Michela Cortesi, Barbara Vergani, Biagio Eugenio Leone, Simona Righi, Anna Gazzola, Beatrice Casadei, Davide Gentilini, Luciano Calzari, Francesco Limarzi, Sabattini Elena, Andrea Pession, Marcella Tazzari, Clara Bertuzzi
Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival. International journal of molecular sciences 24 (12) (2023)
Maria Maddalena Tumedei, Filippo Piccinini, Irene Azzali, Francesca Pirini, Sara Bravaccini, Serena De Matteis, Claudio Agostinelli, Gastone C Castellani, Michele Zanoni, Michela Cortesi, Barbara Vergani, Biagio Eugenio Leone, Simona Righi, Anna Gazzola, Beatrice Casadei, Davide Gentilini, Luciano Calzari, Francesco Limarzi, Sabattini Elena, Andrea Pession, Marcella Tazzari, Clara Bertuzzi
Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival. International journal of molecular sciences 24 (12) (2023)
Maria Maddalena Tumedei, Filippo Piccinini, Irene Azzali, Francesca Pirini, Sara Bravaccini, Serena De Matteis, Claudio Agostinelli, Gastone C Castellani, Michele Zanoni, Michela Cortesi, Barbara Vergani, Biagio Eugenio Leone, Simona Righi, Anna Gazzola, Beatrice Casadei, Davide Gentilini, Luciano Calzari, Francesco Limarzi, Sabattini Elena, Andrea Pession, Marcella Tazzari, Clara Bertuzzi
Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival. International journal of molecular sciences 24 (12) (2023)
Lucia Mazzotti, Anna Gaimari, Sara Bravaccini, Roberta Maltoni, Claudio Cerchione, Manel Juan, Europa Azucena-Gonzalez Navarro, Anna Pasetto, Daniela Nascimento Silva, Valentina Ancarani, Vittorio Sambri, Luana Calabrò, Giovanni Martinelli, Massimiliano Mazza
T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer. International journal of molecular sciences 23 (15) (2022)
Massimo Martino, Virginia Naso, Barbara Loteta, Filippo Antonio Canale, Marta Pugliese, Caterina Alati, Gerardo Musuraca, Davide Nappi, Anna Gaimari, Fabio Nicolini, Massimiliano Mazza, Sara Bravaccini, Daniele Derudas, Giovanni Martinelli, Claudio Cerchione
Chimeric Antigen Receptor T-Cell Therapy: What We Expect Soon. International journal of molecular sciences 23 (21) (2022)
Michela Cortesi, Michele Zanoni, Roberta Maltoni, Sara Ravaioli, Maria Maddalena Tumedei, Francesca Pirini, Sara Bravaccini
TROP2 (trophoblast cell-surface antigen 2): a drug target for breast cancer. Expert opinion on therapeutic targets 26 (7) (2022)
Roberta Maltoni, William Balzi, Tania Rossi, Francesco Fabbri, Sara Bravaccini, Maria Teresa Montella, Oriana Nanni, Lucia Bertoni, Fabio Falcini, Mattia Altini
Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A Study. Current oncology (Toronto, Ont.) 29 (2) (2022)
Sara Bravaccini, Eugenio Fonzi, Michela Tebaldi, Davide Angeli, Giovanni Martinelli, Fabio Nicolini, Paola Parrella, Massimiliano Mazza
Estrogen and Androgen Receptor Inhibitors: Unexpected Allies in the Fight Against COVID-19. Cell transplantation 30 (2021)
Michela Cortesi, Michele Zanoni, Francesca Pirini, Maria Maddalena Tumedei, Sara Ravaioli, Ilario Giovanni Rapposelli, Giovanni Luca Frassineti, Sara Bravaccini
Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight. International journal of molecular sciences 23 (1) (2021)
Sara Bravaccini, Roberta Maltoni
Trop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls. Journal of personalized medicine 11 (11) (2021)
Pasquale Simeone, Stefano Tacconi, Serena Longo, Paola Lanuti, Sara Bravaccini, Francesca Pirini, Sara Ravaioli, Luciana Dini, Anna Maria Giudetti
Expanding Roles of De Novo Lipogenesis in Breast Cancer. International journal of environmental research and public health 18 (7) (2021)
Sara Bravaccini, Patrizia Serra, Dino Amadori, Mattia Altini, Nestory Masalu, Deogratias Katabalo, Lauro Bucchi, Carla Masini
Setting Up a Medical Oncology Educational Program in Sub-Saharan Africa. Annals of global health 87 (1) (2021)
Sara Bravaccini, Giovanni Martinelli, Claudio Cerchione
What Influences the Choice of Ibrutinib-Rituximab vs Classic Chemoimmunotherapy for Chronic Lymphocytic Leukemia? Cell transplantation 29 (2021)
Sara Bravaccini, Giuseppe Bronte, Paola Ulivi
TMB in NSCLC: A Broken Dream? International journal of molecular sciences 22 (12) (2021)
Sara Bravaccini, Licia Caprara, Stefania Cortecchia, Margherita De Lillo, Stefania Lega, Francesca Poli, Ignazio Tasca, Anna Vacirca, Maria Chiara Cimatti, Maria Maddalena Tumedei, Sara Ravaioli, Maurizio Puccetti
Primary epithelioid angiosarcoma of the thyroid: A case report. Cytopathology : official journal of the British Society for Clinical Cytology 32 (4) (2021)
Roberta Maltoni, Michela Palleschi, Sara Ravaioli, Maria Maddalena Tumedei, Andrea Rocca, Elisabetta Melegari, Mattia Altini, Maurizio Puccetti, Silvia Manunta, Sara Bravaccini
Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer. Cell transplantation 29 (2020)
Sara Ravaioli, Francesco Limarzi, Maria Maddalena Tumedei, Michela Palleschi, Roberta Maltoni, Sara Bravaccini
Are we ready to use TMB in breast cancer clinical practice? Cancer immunology, immunotherapy : CII 69 (10) (2020)
Tania Rossi, Daniele Vergara, Francesca Fanini, Michele Maffia, Sara Bravaccini, Francesca Pirini
Microbiota-Derived Metabolites in Tumor Progression and Metastasis. International journal of molecular sciences 21 (16) (2020)
Michela Palleschi, Roberta Maltoni, Sara Ravaioli, Alessandro Vagheggini, Francesca Mannozzi, Francesca Fanini, Francesca Pirini, Maria Maddalena Tumedei, Eleonora Barzotti, Lorenzo Cecconetto, Samanta Sarti, Silvia Manunta, Paola Possanzini, Anna Fedeli, Annalisa Curcio, Mattia Altini, Ugo De Giorgi, Andrea Rocca, Sara Bravaccini
Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience. Diagnostics (Basel, Switzerland) 10 (8) (2020)
Sara Ravaioli, Michela Tebaldi, Eugenio Fonzi, Davide Angeli, Massimiliano Mazza, Fabio Nicolini, Alessandro Lucchesi, Francesca Fanini, Francesca Pirini, Maria Maddalena Tumedei, Claudio Cerchione, Pierluigi Viale, Vittorio Sambri, Giovanni Martinelli, Sara Bravaccini
ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients. Cell transplantation 29 (2020)
Sara Bravaccini, Roberta Maltoni
CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough? Breast cancer research : BCR 21 (1) (2019)
Sara Bravaccini, Lauro Bucchi, Maurizio Puccetti, Sara Ravaioli, Maria Maddalena Tumedei, Patrizia Serra, Carla Masini, Jackson Kahima, Nestory Masalu, Dino Amadori
Explaining the aggressiveness of breast cancer in sub-Saharan African patients. Journal of clinical pathology 72 (10) (2019)
Patrizia Serra, Deogratias M Katabalo, Nestory Masalu, Dino Amadori, Salustia Bugingo, Flavia Foca, Sara Bravaccini, Caterina Donati, Lauro Bucchi, Carla Masini
Evaluating the appropriateness of chemotherapy in a low-resource cancer centre in sub-Saharan Africa. Cancer medicine 9 (1) (2019)
Sung Pil Hong, Thalia E Chan, Ylenia Lombardo, Giacomo Corleone, Nicole Rotmensz, Sara Bravaccini, Andrea Rocca, Giancarlo Pruneri, Kirsten R McEwen, R Charles Coombes, Iros Barozzi, Luca Magnani
Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy. Nature communications 10 (1) (2019)
Giuseppe Bronte, Andrea Rocca, Sara Ravaioli, Emanuela Scarpi, Massimiliano Bonafè, Maurizio Puccetti, Roberta Maltoni, Daniele Andreis, Giovanni Martinelli, Sara Bravaccini
Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer? Journal of oncology 2019 (2019)
Roberta Maltoni, Sara Bravaccini
What is the best clinical pathological score to identify high-risk patients with lobular carcinoma of the breast who are likely to benefit from adjuvant chemotherapy? Breast cancer research and treatment 177 (1) (2019)
Sara Bravaccini, Giuseppe Bronte
Petals and thorns in programmed death-ligand 1 testing: Is all non-small cell lung cancer diagnostic material suitable? Cancer cytopathology 126 (9) (2018)
Maurizio Puccetti, Sara Ravaioli, Maria M Tumedei, Elisa Bucchi, Manuela Malmesi, Laura Medri, Sara Bravaccini
Are fine-needle aspiration biopsy-derived cell blocks a useful surrogate for tissue samples in breast cancer? Histopathology 73 (5) (2018)
Sara Bravaccini, Andrea Rocca, Giuseppe Bronte
Is Ki67 still a powerful ally in predicting the clinical benefit of anthracyclines for the adjuvant treatment of early breast cancer? Breast cancer research and treatment 168 (3) (2018)
Giuseppe Bronte, Sara Ravaioli, Sara Bravaccini
What to look for in cell-free DNA from breast cancer patients. Breast cancer research and treatment 170 (1) (2018)
Delia Cavallo, Valentina Casadio, Sara Bravaccini, Sergio Iavicoli, Enrico Pira, Canzio Romano, Anna Maria Fresegna, Raffaele Maiello, Aureliano Ciervo, Giuliana Buresti, Wainer Zoli, Daniele Calistri
Assessment of DNA damage and telomerase activity in exfoliated urinary cells as sensitive and noninvasive biomarkers for early diagnosis of bladder cancer in ex-workers of a rubber tyres industry. BioMed research international 2014 (2014)

Sara Bravaccini.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sara Bravaccini